A World First VivaChek Blood Glucose and β-Ketone Dual Monitoring System Receives FDA 510(k) Clearance

Release date:21/10/2026

A World First | VivaChek Blood Glucose and β-Ketone Dual Monitoring System Receives FDA 510(k) Clearance

We are pleased to announce that VivaChek Blood Glucose and β-Ketone Dual Monitoring System has received 510(k) clearance from the U.S. Food and Drug Administration (FDA), marking a significant milestone in the company's advancement of diabetes care.


One Meter. One Test Strip. Two Results.

Designed to integrate blood glucose and β-ketone testing into a single system, the device uses one test strip for both measurements. Using a fingertip blood sample of 1.6 μL, it provides blood glucose and β-ketone results within 12 seconds.

This integrated solution is ideal for individuals with diabetes requiring insulin therapy, and users who need to closely monitor blood ketone levels. Such an integrated design represents an innovative approach to dual-analyte monitoring, combining two essential measurements in one device and further expanding VivaChek's POCT multi-analyte testing product line .


Advancing Innovation in Diabetes Monitoring

By bringing blood glucose and β-ketone testing together in one system, VivaChek advances innovation in diabetes monitoring. This milestone reflects the company's ongoing mission to make health management more accessible through advanced monitoring solutions.